Latest Breaking News On - Action potential duration - Page 1 : comparemela.com

/PRNewswire/ - Thryv Therapeutics Inc., a biopharmaceutical company focused on a precision medicine approach to treat Long QT Syndrome (LQTS) via SGK1.

United statesSan antonioPhilip sagerMichael ackermanThryv therapeutics incTherapeutics incPharmacological research in cardiac electrophysiologyAmerican heart association scientific sessionsGlucocorticoid regulatedCongenital longGenotype specific re engineered heart cellsChief medical officerAction potential durationRe engineered heart cell modelsTherapeutic approachesMayo clinic